Andrew Scott Walton

Andrew Scott Walton currently works at Millennium Health LLC, as Chief Executive Officer from 2021, Orchid Cellmark, Inc., as Director, Monogram Biosciences, Inc., as Director, Oxford Immunotec Ltd., as Director from 2015, and Quest Diagnostics TB LLC, as Director from 2015.
Mr. Walton also formerly worked at Inform Diagnostics, Inc., as Chief Executive Officer from 2017 to 2018, Ameritox LLC, as President & Chief Executive Officer from 2012 to 2017, Oxford Immunotec Global Ltd., as Independent Non-Executive Director from 2015 to 2021, Laboratory Corp.
of America Holdings, as Executive Vice President-Esoteric Business from 2010 to 2012, Ernst & Young LLP, as Principal, KPMG LLP, as Principal, and Subsidium Health Advisors LLC, as Partner from 2002 to 2005.
Mr. Walton received his undergraduate degree from Yale University and Masters Business Admin degree from Harvard Business School.